Targeted therapies in thyroid cancer
โ Scribed by Jaume Capdevila; Jose Perez-Garcia; Gabriel Obiols; Josep Tabernero
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 314 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1776-2596
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T
## Opinion statement The prognosis and long-term survival for patients with metastatic esophagogastric cancer (EGC) is poor. Historically, the mainstay of treatment has been combination chemotherapy. More recently, a number of targeted therapies have been developed and are being studied with the go